Delivery Order SPE2DB24D3013-SPE2DB24FFGFL

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Tabrecta 200 mg tablets to the Defense Logistics Agency (DLA). The $6,547.42 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs. The contract has a completion date of November 20, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This federal contract award is a delivery order valued at $13,094.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through November 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,094.84 firm fixed-price delivery order is for the supply of 4566306589 TABRECTA 200 MG TABLET UU 56S, with a completion date of November 25, 2024. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $13,547.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TABRECTA 200 MG TABLET UU 56S, a specialty medication, with a completion date of December 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $6,547.42 firm fixed-price delivery order covers the supply of TABRECTA 200 MG TABLET, a pharmaceutical product, to support government healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm fixed-price delivery order contract is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of June 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $13,094.84 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary...
This Federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,428.06, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $13,094.84, is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, under a firm fixed price delivery order. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGFL
    Delivery Order

This federal contract award is for the delivery of TABRECTA 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $13,094.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, through its extensive pharmaceutical distribution network, is well-positioned to efficiently fulfill the government's requirements for essential medical commodities.

Generated 10/14/24, 10:24 AM